Checkpoint Therapeutics, Inc. (CKPT) Stock Undergoes Volatility after Release of Q1 2021 Financial Reports
Checkpoint Therapeutics, Inc. (CKPT) stock prices were up 4.17% as of the market closing on May 11th, 2021, bringing the price per share up to USD$2.50. Subsequent pre-market fluctuations have seen the stock fall 9.20%, down to USD$2.27. Cosibelimab Development The company recently reported the continued advancement of the development of CKPT’s two lead drug […]
